KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to 17.15%.

  • Bio-Rad Laboratories' EBITDA Margin fell 258900.0% to 17.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.83%, marking a year-over-year decrease of 86500.0%. This contributed to the annual value of 1.83% for FY2025, which is 86500.0% down from last year.
  • Bio-Rad Laboratories' EBITDA Margin amounted to 17.15% in Q4 2025, which was down 258900.0% from 10.0% recorded in Q3 2025.
  • Bio-Rad Laboratories' EBITDA Margin's 5-year high stood at 20.99% during Q3 2021, with a 5-year trough of 17.15% in Q4 2025.
  • Over the past 5 years, Bio-Rad Laboratories' median EBITDA Margin value was 13.89% (recorded in 2022), while the average stood at 11.93%.
  • Per our database at Business Quant, Bio-Rad Laboratories' EBITDA Margin skyrocketed by 77900bps in 2021 and then plummeted by -258900bps in 2025.
  • Over the past 5 years, Bio-Rad Laboratories' EBITDA Margin (Quarter) stood at 16.09% in 2021, then rose by 1bps to 16.25% in 2022, then fell by -14bps to 13.99% in 2023, then tumbled by -38bps to 8.73% in 2024, then tumbled by -296bps to 17.15% in 2025.
  • Its last three reported values are 17.15% in Q4 2025, 10.0% for Q3 2025, and 11.83% during Q2 2025.